Evotec SE
FSX:EVT.DE
Overview | Financials
Company Name | Evotec SE |
Symbol | EVT.DE |
Currency | EUR |
Price | 7.255 |
Market Cap | 1,286,333,882 |
Dividend Yield | 0% |
52-week-range | 5.06 - 21.69 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Werner Lanthaler M.B.A., MBA, MPA, Ph.D. |
Website | https://www.evotec.com |
An error occurred while fetching data.
About Evotec SE
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD